Diffusion of aniline blue injected into the thyroarytenoid muscle as a proxy for botulinum toxin injection: an experimental study in cadaver larynges

Summary

Introduction: Endolaryngeal injection of botulinum toxin into the thyroarytenoid (TA) muscle is one of the methods for treatment of focal laryngeal dystonia. However, after treatment, there is variation in laryngeal configuration as well as the side effects reported by patients. As a consequence of the functional variability of results, it was hypothesized that botulinum toxin diffuses beyond the limits of the muscle into which it is injected.

Objectives: After injection of botulinum toxin into the TA muscle for the treatment of focal laryngeal dystonia, patients differ in terms of laryngeal configuration and side effects. We hypothesized that this toxin diffuses from the target muscle to adjacent muscles.

Method: The TA muscles of 18 cadaver larynges were injected with aniline blue (0.2 mL). After fixation in formaldehyde and nitric acid decalcification, the larynges were sectioned in the coronal plane and the intrinsic muscles were analyzed.

Results: We found diffusion of aniline blue to the lateral cricoarytenoid muscle, cricothyroid muscle, and posterior cricoarytenoid muscle in 94.3%, 42.9%, and 8.6% of the cases, respectively. In terms of the degree of diffusion to adjacent muscles, we found no differences related to the size (height and width) of the TA muscle or to gender.

Conclusions: Our findings suggest that diffusion of botulinum toxin from its injection site in the TA muscle to the lateral cricoarytenoid muscle is likely in most cases. On the other hand, diffusion to the cricothyroid muscle occurs in approximately half of cases and diffusion to the posterior cricoarytenoid muscle occurs in very few cases.

Keywords

Larynx - Dysphonia - Botulinum Toxins - Diffusion - Biological Transport

• References

• 1 Behlau MS, Pontes PAL, Dedo HH. Spastic Dysphonia of the focal laryngeal dystonia: the evolution of the concept of the same disease. Acta AWHO 1991; 10 (2) 89-95
• 2 Tsuji DH, Sennes LU, Pinho SMR, Barbosa E. Technical application of botulinum toxin through the flexible endoscopel. In: Third Brazilian Congress from Laryngology and Voice, Annals. 1995. ; P 1
• 3 Blitzer A, Brin MF, Fahn S , et al. Botulinum toxin (BOTOX) for the treatment of “Spastic Dysphonia”as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope 1986; 96: 1300-1
• 4 Evans CM, Williams RS, Shone CC. Botulinum type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem 1986; 154: 409-16
• 5 Tsuji DH, Sennes LU, Imamura R, Koishi HV. Technical Injection of Botulinum Toxin by flexible endoscopel. Arq Fund Otorrinolaringol 2001; 5 (3) 137-43
• 6 Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis. Dysphagia and regional toxin spread. Otolaryngol Head Neck Surg 1990; 12: 392-8
• 7 Shaari CM, George E, Wu BL, Biller HF, Sanders I. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 1991; 101: 960-4
• 8 Ludlow CL, Naunton RF, Sedory SE. Effects of Botulinum Toxin Injections on Speech in Adductor Spasmodic Dysphonia. Neurology 1988; 38: 1220-5
• 9 Ludlow CL, Bagley JA, Yin SG. A comparison of different injection techniques in the treatment of spasmodic dysphonia with botulinum toxin. J Voice 1992; 6: 380-6
• 10 Brin MF, Blitzer A, Fahn S et al. Adductor Laryngeal Dystonia (Spastic Dysphonia): Treatment with Local Injections of Botulinum Toxin (BOTOX). Mov Disord 1989; 4: 287-96
• 11 Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc 1981; 79: 734-70
• 12 Elston JS, Russel RW. Effects of Treatment with Botulinum Toxin on Neurogenic Blepharospasm. Br Med J 1985; 290: 1857-9
• 13 Hallan RI, Melling J, Womack NR. Treatment of Anismus in Intractable Constipation with Botulinum A. Toxin. Lancet 1988; 2: 714-7
• 14 Stell R, Thompson PD, Marsden CD. Botulinum Toxin in Spasmodic Torticollis. J Neurol Neurosurg Psychiatry 1988; 51: 920-3
• 15 Koay CE, Alun-Jones T. Pharyngeal Paralysis Due to Botulinum Toxin Injection. J Laryngol Otol 1989; 103: 698-9
• 16 Liu TC, Irish JC, Adams SG, Durkin LC, Hunt EJ. Prospective Study of Pacients'Subjective Responses to Botulinum Toxin Injection for Spasmodic Dysphonia. J Otolaryngol 1996; 25 (2) 66-74
• 17 Venkatesan NN, Johns MM, Hapner ER, DelGaudio JM. Abductor paralysis after botox injection for adductorspasmodic dysphonia. Laryngoscope 2010; Jun; 120 (6) 1177-80